PFE (Pfizer) How high will it go? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go?

PFE 25.44

+1.5%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: BigKNY3 who wrote (7261)	3/22/1999 12:16:00 PM
From: Anthony Wong	Read Replies (1) of 9523

3/22 (Dow Jones) Celebrex Prescriptions In 9th Wk Top Viagra's 9-Wk Mark By Otesa Middleton WASHINGTON (Dow Jones)--Monsanto Co.'s (MTC) Celebrex had more prescriptions written in its ninth week on the market than Pfizer Inc.'s (PFE) Viagra tallied in its ninth week. Celebrex, a new drug for osteoarthritis and rheumatoid arthritis, recorded 279,183 prescriptions for the week ended March 12. According to pharmaceutical auditor IMS Health Inc. (RX), that is up 5.8% when compared with prescriptions written in the eighth week. For the first time, Celebrex prescriptions surpassed those written for Viagra during a comparable period. In the impotence drug's ninth week on the market, it recorded 210,857 prescriptions. Since Celebrex went on sale Jan. 15, 1.2 million prescriptions have been written for it. Celebrex is a new type of arthritis medicine. It is thought to be easier on the stomach than other treatments because it attacks a specific enzyme called Cox-2. The first such Cox-2 drug, Celebrex may face competition from Merck & Co. (MRK), which takes its Cox-2 drug Vioxx to a U.S. Food and Drug Administration panel April 20. -Otesa Middleton; 202-862-6654 (END) DOW JONES NEWS 03-22-99 10:27 AM

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next